Status:
RECRUITING
Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)
Lead Sponsor:
University of Pittsburgh
Conditions:
Pulmonary Fibrosis
Eligibility:
All Genders
18+ years
Brief Summary
The purposes of this study are: * to determine if there are specific genetic traits that might explain why patients have developed pulmonary fibrosis; * to determine if specific genetic traits accoun...
Detailed Description
Idiopathic pulmonary fibrosis (IPF) is a disease of unknown etiology that is characterized by the insidious development of lung fibrosis ultimately leading to distortion of the lung architecture, resp...
Eligibility Criteria
Inclusion
- 18 years of age or older
- Diagnosis of pulmonary fibrosis confirmed by physical examination, pulmonary function testing, chest X-ray, and computed tomography (CT) scans.
- Adult patients who are seeking treatment at the Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease.
Exclusion
- Under 18 years of age
- Non-fibrotic ILD
Key Trial Info
Start Date :
January 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2035
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT00258570
Start Date
January 1 2003
End Date
July 1 2035
Last Update
November 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15213